Bellevue Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-9,000
| Closed | -$660K | – | 170 |
|
2022
Q4 | $660K | Buy |
+9,000
| New | +$660K | 0.01% | 149 |
|
2022
Q3 | – | Sell |
-25,300
| Closed | -$1.76M | – | 181 |
|
2022
Q2 | $1.76M | Buy |
25,300
+16,800
| +198% | +$1.17M | 0.02% | 133 |
|
2022
Q1 | $704K | Buy |
+8,500
| New | +$704K | 0.01% | 153 |
|